4.4 Article

Pregnancy and autoimmune connective tissue diseases

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2016.05.002

Keywords

Antiphospholipid antibody syndrome; Autoimmunity; Myositis; Pregnancy; Rheumatoid arthritis; Scleroderma; Sjogren's syndrome; Systemic lupus erythematosus

Categories

Funding

  1. NIH [K01ES019909]
  2. Department of Veterans Affairs, Veterans Health Administration

Ask authors/readers for more resources

Autoimmune connective tissue diseases predominantly affect women and often occur during the reproductive years. Thus, specialized issues in pregnancy planning and management are commonly encountered in this patient population. This chapter provides a current overview of pregnancy as a risk factor for onset of autoimmune disease, considerations related to the course of pregnancy in several autoimmune connective tissue diseases, and disease management and medication issues before pregnancy, during pregnancy, and in the postpartum period. A major theme that has emerged across these inflammatory diseases is that active maternal disease during pregnancy is associated with adverse pregnancy outcomes, and that maternal and fetal health can be optimized when conception is planned during times of inactive disease and through maintaining treatment regimens compatible with pregnancy. (C) 2016 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available